Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abraham Avigdor

Showing results (71-80 of 118) with videos related to

Pageof 12
Sort By:
Annals of Hematology|January 28, 2022
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocolDanielle Fredman, Yakir Moshe, Ofir Wolach, et al.
Blood|April 9, 2004
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrowAbraham Avigdor, Polina Goichberg, Shoham Shivtiel, et al.
Transplantation and Cellular Therapy|February 26, 2022
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaMeirav Kedmi, Roni Shouval, Shalev Fried, et al.
Rheumatology (Oxford, England)|April 5, 2026
Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous hematopoietic stem cell transplantation: a case seriesDoron Rimar, Paula David, Elad Jacoby, et al.
Cancer Research|November 17, 2006
Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cellsAlexander Kalinkovich, Sigal Tavor, Abraham Avigdor, et al.
Genes, Chromosomes & Cancer|May 7, 2016
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Merav Leiba, Adrian Duek, Ninette Amariglio, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Blood Advances|January 8, 2025
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cellsInbal Sdayoor, Roni Shouval, Shalev Fried, et al.
Annals of Hematology|March 6, 2014
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphomaAbraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2007
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapyDita Gratzinger, Shuchun Zhao, Robert J Tibshirani, et al.
Pageof 12

Showing results (71-80 of 118) with videos related to

Sort By:
Pageof 12
Annals of Hematology|January 28, 2022
Evaluating outcomes of adult patients with acute lymphoblastic leukemia and lymphoblastic lymphoma treated on the GMALL 07/2003 protocolDanielle Fredman, Yakir Moshe, Ofir Wolach, et al.
Blood|April 9, 2004
CD44 and hyaluronic acid cooperate with SDF-1 in the trafficking of human CD34+ stem/progenitor cells to bone marrowAbraham Avigdor, Polina Goichberg, Shoham Shivtiel, et al.
Transplantation and Cellular Therapy|February 26, 2022
Point-of-care anti-CD19 CAR T-cells for treatment of relapsed and refractory aggressive B-cell lymphomaMeirav Kedmi, Roni Shouval, Shalev Fried, et al.
Rheumatology (Oxford, England)|April 5, 2026
Anti-CD19 CAR-T cell therapy as rescue treatment in systemic sclerosis relapsing after autologous hematopoietic stem cell transplantation: a case seriesDoron Rimar, Paula David, Elad Jacoby, et al.
Cancer Research|November 17, 2006
Functional CXCR4-expressing microparticles and SDF-1 correlate with circulating acute myelogenous leukemia cellsAlexander Kalinkovich, Sigal Tavor, Abraham Avigdor, et al.
Genes, Chromosomes & Cancer|May 7, 2016
Translocation t(11;14) in newly diagnosed patients with multiple myeloma: Is it always favorable?Merav Leiba, Adrian Duek, Ninette Amariglio, et al.
Nature Communications|September 23, 2021
Targeting the actin nucleation promoting factor WASp provides a therapeutic approach for hematopoietic malignanciesGuy Biber, Aviad Ben-Shmuel, Elad Noy, et al.
Blood Advances|January 8, 2025
Pretreatment pulmonary function testing has limited utility in B-cell lymphoma treated with CD19 CAR T cellsInbal Sdayoor, Roni Shouval, Shalev Fried, et al.
Annals of Hematology|March 6, 2014
The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphomaAbraham Avigdor, Tsvi Sirotkin, Meirav Kedmi, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|November 14, 2007
Prognostic significance of VEGF, VEGF receptors, and microvessel density in diffuse large B cell lymphoma treated with anthracycline-based chemotherapyDita Gratzinger, Shuchun Zhao, Robert J Tibshirani, et al.
Pageof 12